Poland’s Polpharma asks US court to grant Swiss arbitration in TS case

08-07-2021

Alex Baldwin

Poland’s Polpharma asks US court to grant Swiss arbitration in TS case

Sergiy Palamarchuk / Shutterstock.com

Poland’s largest pharmaceutical company has asked the federal court to let it pursue arbitration in a Swiss court for a trade secrets dispute between India’s Rubicon Research and North Carolina biotech firm Kartha Pharmaceuticals.


Zakłady Farmaceutyczne Polpharma, Kartha Pharmaceuticals, Rubicon, Swiss Chambers, arbitration, Baclofen

LSIPR